再生元制药 REGN 深 沪
等待开盘 05-12 09:30:00 美东时间
711.56
-2.490
-0.35%
华盛通- 最 高727.385
- 今 开714.99
- 成交量 46.50万股
- 最 低 702.50
- 昨 收 714.05
- 总市值 7827.16万
- 52周最高 821.11
- 市盈率 静 9.89
- 换手率 422.74%
- 52周最低 476.4869
- 委 比 23.08%
- 总股本 0.00亿
- 历史最高 1211.1999
- 量 比 1.58
- 振 幅 3.49%
- 历史最低 1.10
- 每 手 1
- 风险率 98.88%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Regeneron Flags FDA Delays For Eylea HD Prefilled Syringe
Regeneron beats Q1 estimates as Eylea HD demand rises, while margins narrow and FDA decisions on manufacturing remain pending.
04-30 01:57
Auddia Shares Sink After $12 Million Offering As Volatility Spikes
Auddia stock plunges over 60% after pricing a $12M public offering, reversing gains and trading near 52-week lows.
04-25 01:07
Regeneron Strikes Deal With Trump Administration To Cut Drug Prices
Regeneron agrees to cut U.S. drug prices, offers free gene therapy, and expands access under a deal with the Trump administration.
04-25 00:08
FDA Approval Broadens Dupixent Use While Sanofi Posts Earnings Beat
Sanofi, Regeneron win FDA nod for Dupixent in pediatric CSU as Q1 sales beat estimates, driven by strong Dupixent growth.
04-23 23:02
Ocular's Axpaxli Cuts Risk Of Worsening In Late-Stage AMD Study
Ocular Therapeutix shares up on positive data for wet AMD treatment. Company focusing on retinal diseases and on track for FDA submission.
04-14 01:31
Telix Pharma Gains As Regeneron Tie-Up Targets Solid Tumor Programs
Telix collaborates with Regeneron, targeting radiopharmaceutical development, with milestones up to $2.1 billion and royalties.
04-13 20:38
From Lungs To Nasal Polyps: Sanofi Finds Success With 2-in-1 Inflammation Blocker
Sanofi reports positive Phase 2 data for lunsekimig in asthma and nasal polyps, while atopic dermatitis study misses main goal.
04-07 19:02
Eupraxia Pharmaceuticals Boasts $900 Million Peak Sales Potential: Analyst
William Blair starts Eupraxia at Outperform as the analyst flags unmet need and sizable market potential.
03-24 01:59
P/E Ratio Insights for Regeneron Pharmaceuticals
In the current market session, Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) sto...
03-05 06:00
Why Is CRISPR Therapeutics Stock Surging Thursday?
CRSP shares jump on earnings report, strong pipeline for gene therapy. Revenue grows with increased patient treatment and analyst confidence.
02-27 02:45
